 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - MENDLEIN JOHN
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-12-19 Purchase | 2016-12-21 11:54 am | aTYR PHARMA INC | LIFE | MENDLEIN JOHN CEO | 69,000 | $2.198 | $151,662 | 324,971 (Direct) | View |
| 2017-04-18 Purchase | 2017-04-20 7:04 pm | aTYR PHARMA INC | LIFE | MENDLEIN JOHN CEO | 2,552 | $3 | $7,656 | 327,523 (Direct) | View |
| 2017-04-24 Purchase | 2017-04-26 5:02 pm | aTYR PHARMA INC | LIFE | MENDLEIN JOHN CEO | 124 | $3 | $372 | 327,647 (Direct) | View |
| 2017-08-31 Purchase | 2017-09-05 7:41 pm | aTYR PHARMA INC | LIFE | MENDLEIN JOHN CEO | 37,736 | $2.65 | $100,000 | 367,883 (Direct) | View |
| 2018-12-20 Purchase | 2018-12-26 4:15 pm | aTYR PHARMA INC | LIFE | MENDLEIN JOHN Director | 245,000 | $0.42142 | $103,247 | 615,382 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-05-11 Option Award | 2016-05-13 1:04 pm | N/A 2026-05-10 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2017-02-07 Option Award | 2017-02-09 4:27 pm | N/A 2027-03-07 | aTYR PHARMA INC | LIFE | MENDLEIN JOHN CEO | 185,000 | $0 | 185,000 (Direct) | View |
| 2017-05-02 Option Award | 2017-05-04 12:02 pm | N/A 2027-05-01 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2017-06-15 Option Award | 2017-06-19 4:09 pm | N/A 2027-06-14 | Editas Medicine Inc. | EDIT | MENDLEIN JOHN Director | 11,538 | $0 | 11,538 (Direct) | View |
| 2017-08-31 Purchase | 2017-09-05 7:41 pm | 2017-08-31 2019-12-31 | aTYR PHARMA INC | LIFE | MENDLEIN JOHN CEO | 14,151 | $0 | 14,151 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-02 7:49 pm | N/A 2028-01-02 | aTYR PHARMA INC | LIFE | MENDLEIN JOHN Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2018-05-02 Option Award | 2018-05-04 4:19 pm | N/A 2028-05-02 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2018-05-15 Option Award | 2018-05-17 4:32 pm | N/A 2028-05-15 | aTYR PHARMA INC | LIFE | MENDLEIN JOHN Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2019-05-03 Option Award | 2019-05-07 4:05 pm | N/A 2029-05-03 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2019-05-08 Option Award | 2019-05-10 5:29 pm | N/A 2029-05-08 | aTYR PHARMA INC | LIFE | MENDLEIN JOHN Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-05 4:17 pm | N/A 2030-05-01 | FATE THERAPEUTICS INC | FATE | MENDLEIN JOHN Director | 16,000 | $0 | 16,000 (Direct) | View |